These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Progress in the genetics of primary biliary cirrhosis. Hirschfield GM; Invernizzi P Semin Liver Dis; 2011 May; 31(2):147-56. PubMed ID: 21538281 [TBL] [Abstract][Full Text] [Related]
29. Genome-wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis. Wang C; Zheng X; Jiang P; Tang R; Gong Y; Dai Y; Wang L; Xu P; Sun W; Wang L; Han C; Jiang Y; Wei Y; Zhang K; Wu J; Shao Y; Gao Y; Yu J; Hu Z; Zang Z; Zhao Y; Wu X; Dai N; Liu L; Nie J; Jiang B; Lin M; Li L; Li Y; Chen S; Shu L; Qiu F; Wu Q; Zhang M; Chen R; Jawed R; Zhang Y; Shi X; Zhu Z; Pei H; Huang L; Zhao W; Tian Y; Zhu X; Qiu H; Gershwin ME; Chen W; Seldin MF; Liu X; Sun L; Ma X Hepatology; 2019 Jul; 70(1):294-307. PubMed ID: 30854688 [TBL] [Abstract][Full Text] [Related]
30. The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases. Parikh-Patel A; Gold E; Mackay IR; Gershwin ME Clin Immunol; 1999 May; 91(2):206-18. PubMed ID: 10227813 [TBL] [Abstract][Full Text] [Related]
31. NFKB1 and MANBA Confer Disease Susceptibility to Primary Biliary Cholangitis via Independent Putative Primary Functional Variants. Hitomi Y; Nakatani K; Kojima K; Nishida N; Kawai Y; Kawashima M; Aiba Y; Nagasaki M; Nakamura M; Tokunaga K Cell Mol Gastroenterol Hepatol; 2019; 7(3):515-532. PubMed ID: 30528300 [TBL] [Abstract][Full Text] [Related]
32. rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitis. Hitomi Y; Aiba Y; Kawai Y; Kojima K; Ueno K; Nishida N; Kawashima M; Gervais O; Khor SS; Nagasaki M; Tokunaga K; Nakamura M; Tsuiji M Sci Rep; 2021 Feb; 11(1):4557. PubMed ID: 33633225 [TBL] [Abstract][Full Text] [Related]
33. Genome-wide haplotype association analysis of primary biliary cholangitis risk in Japanese. Im C; Sapkota Y; Moon W; Kawashima M; Nakamura M; Tokunaga K; Yasui Y Sci Rep; 2018 May; 8(1):7806. PubMed ID: 29773854 [TBL] [Abstract][Full Text] [Related]
34. Primary biliary cirrhosis: does X mark the spot? Selmi C; Invernizzi P; Miozzo M; Podda M; Gershwin ME Autoimmun Rev; 2004 Nov; 3(7-8):493-9. PubMed ID: 15546796 [TBL] [Abstract][Full Text] [Related]
35. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Selmi C; Mayo MJ; Bach N; Ishibashi H; Invernizzi P; Gish RG; Gordon SC; Wright HI; Zweiban B; Podda M; Gershwin ME Gastroenterology; 2004 Aug; 127(2):485-92. PubMed ID: 15300581 [TBL] [Abstract][Full Text] [Related]
38. Association of human leukocyte antigen class II with susceptibility to primary biliary cirrhosis: a systematic review and meta-analysis. Qin B; Wang J; Chen J; Liang Y; Yang Z; Zhong R PLoS One; 2013; 8(11):e79580. PubMed ID: 24265779 [TBL] [Abstract][Full Text] [Related]
39. Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis. Umemura T; Joshita S; Ichijo T; Yoshizawa K; Katsuyama Y; Tanaka E; Ota M; Hepatology; 2012 Feb; 55(2):506-11. PubMed ID: 21953406 [TBL] [Abstract][Full Text] [Related]
40. Primary biliary cholangitis: A tale of epigenetically-induced secretory failure? Rodrigues PM; Perugorria MJ; Santos-Laso A; Bujanda L; Beuers U; Banales JM J Hepatol; 2018 Dec; 69(6):1371-1383. PubMed ID: 30193962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]